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DISCUSSION
Figure 1. CT chest without 
evidence of pulmonary sarcoidosis 
 •  Sarcoidosis is a systemic disease of unknown 
etiology characterized by non-caseating 
granuloma formation affecting primarily 
young individuals aged 20-39.4
 •  In over 90 percent of the cases sarcoidosis 
targets the lungs or the related lymph nodes 
but it can affect any organ system.4
 •  A 70-year-old Caucasian female presented to the emergency department with symptoms of confusion and low back 
pain. She was found to have an elevated calcium level of 14 mg/dL, creatinine of 3.8 mg/dL with a baseline of 1.3 
mg/dL, and a hemoglobin of 10 g/dL with a baseline of 12 g/dL. 
 •  X-ray imaging of the lumbar spine was concerning for a compression fracture with osteolytic changes. 
 •  She was treated with intravenous hydration and calcitonin with correction of her renal and electrolyte abnormalities.
 •  Her presentation raised concern for multiple myeloma and work up was initiated. 
 •  Surprisingly, the bone marrow biopsy demonstrated granulomatous inflammation.  
 •  In addition, laboratory data revealed SPEP/UPEP negative for monoclonal gammopathy, as well as elevated 
1,25-dihydroxyvitamin D and angiotensin converting enzyme (ACE) levels. 
 •  A skeletal survey was performed for completion and was unremarkable for additional bony abnormalities.
 •  Additional laboratory data performed in context of hypercalcemia work up was also unrevealing as seen in Table 2. 
 •  Inconsistent with the diagnosis, CT of the chest was negative for parenchymal or lymph node involvement of the 
pulmonary system. 
 •  Patient also displayed potential cardiac manifestations of her disease given history of conduction abnormalities 
requiring a pacemaker as well as a diagnosis of diastolic dysfunction. 
 •  This information supported the diagnosis of sarcoidosis. 
 •  Isolated extrapulmonary manifestations of sarcoidosis are rare and present in less 
than 10 percent of reported cases.1
 •  Bone marrow involvement has only been described in less than 5 percent of 
cases.3
 •  This is potentially due to a low number of bone biopsies performed and could 
underrepresent the true incidence of bone marrow sarcoidosis.3
 •  Sarcoid can present as sclerotic or lytic lesions on radiographic data.6
 •  Hematologic abnormalities can be seen in up to 30 percent of cases.5
 •  Steroids are first line therapy for any manifestation of sarcoidosis.2
 •  While there is a broad differential for granulomatous lesions the clinical picture of 
the patient presented is less likely a result of other infectious, vasculitic, neoplastic, 
or chemical/environmental etiologies. 
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Figure 2. Granulomatous 
Inflammation
 FOLLOW-UP
 •  Patient was discharged on a year long steroid taper without recurrence of hypercalcemia during the course of the 
year. 
 •  Her hemoglobin increased from 10 g/dL on initial presentation to her baseline of 12 g/dL. 
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Table 2.   
Parathyroid Hormone 6.2 pg/mL
Parathyroid Related Peptide 3.4 pml/L
Angiotensin Converting Enzyme 89 U/L
1,25-OH 143/pg/mL
25-OH 25 ng/mL
Alkaline Phosphatase 69 U/L
